General Atlantic $220 million acquisition of a majority stake in Rubicon Research

10/4/2019

Private acquisition

Dollar value:

$ 220 million

Status:

Completed

Date:

10/4/2019

Overview:

Growth equity investor General Atlantic has acquired a majority stake in contract research and a drug delivery company Rubicon Research for approximately $220 million.

Shah Shameer Ahmed - Researcher

Jurisdiction:

India

Deal type:

Private acquisition

Practice area:

Private equity

Industry sector:

Pharmaceuticals and life sciences

Firm:

AZB & Partners

Party: Rubicon Research (Target)

Lawyer: Anand Shah

Related deals